98%
921
2 minutes
20
Purpose: The coexistence of insomnia and obstructive sleep apnea (OSA) is very prevalent. Hypoglossal nerve stimulation (HGNS) is an established second-line therapy for patients suffering OSA. Studies investigating the effect of the different aspects of insomnia on the therapeutic outcome are largely missing. Therefore, this study aimed to understand the impact of the different aspects of insomnia on the therapeutic outcome under HGNS therapy in clinical routine.
Patients And Methods: This is a retrospective study including 30 consecutive patients aged 55.40 ± 8.83 years (8 female; 22 male) undergoing an HGNS implantation in our tertiary medical center between 2020 and 2023. All patients underwent preoperative polysomnography (PSG) according to AASM. First follow-up PSG was performed 95.40 ± 39.44 days after activation (30 patients) and second follow-up PSG was performed 409.89 ± 122.52 days after activation (18 patients). Among others, the following PSG-related parameters were evaluated: apnea-hypopnea index (n/h) (AHI) and oxygen desaturation index (n/h) (ODI). Insomnia was assessed by the insomnia severity index (ISI) questionnaire. Preoperatively, all patients included filled out each ISI item. Spearman's-rho correlation coefficient was calculated for correlations.
Results: Preoperative score of ISI item 1 (difficulty falling asleep) was 1.93 ± 1.34 and preoperative cumulative ISI score (item1-7) was 18.67 ± 5.32. Preoperative AHI was 40.61 ± 12.02 (n/h) and preoperative ODI was 38.72 ± 14.28 (n/h). In the second follow-up, the mean difference in AHI was ∆ 10.47 ± 15.38 (n/h) and the mean difference in ODI was ∆ 8.17 ± 15.67 (n/h). Strong significant correlations were observed between ISI item 1 (difficulty falling asleep) and both ∆ AHI (r: -0.65, =0.004) and ∆ ODI (r: -0.7; =0.001) in the second follow-up.
Conclusion: Difficulty falling asleep may hence negatively influence HGNS therapeutic outcome. Insomnia-related symptoms should be considered in the preoperative patient evaluation for HGNS.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11192637 | PMC |
http://dx.doi.org/10.2147/NSS.S459690 | DOI Listing |
Clin Kidney J
September 2025
Department of Nephrology, CHU Lyon, Lyon, France.
Background: Patients receiving haemodialysis (HD) experience symptoms that impact quality of life. This study assessed the concordance of symptoms and symptom severity of HD patients and their perception by nurses and nephrologists.
Methods: A cross-sectional, observational study using the 30-item Dialysis Symptom Index (DSI) questionnaire was conducted in six dialysis centres in France from 1 March 2022 to 30 June 2023.
J Addict Nurs
September 2025
Annika Norell, PhD, School of Behavioral, Social and Legal Sciences, Örebro University, Örebro, Sweden; Faculty of Health Sciences, Kristianstad University, Kristianstad, Sweden.
Background: Although there is substantial evidence of the negative impact of caffeine use on sleep quality, few studies focus specifically on adolescents' patterns of use. This study aimed to identify patterns of caffeine use among adolescents and analyze their association with sleep quality.
Method: A cross-sectional study was conducted in southern Sweden including 1,404 adolescents aged 15-17 (56.
Objective: To investigate associations between religiosity/spirituality and sleep and potential modification by stress among Black/African American (AA) women.
Methods: Using data from the Study of Environment, Lifestyle, & Fibroids at enrollment (2010- 2012) and three follow-up periods (2012-2018), we estimated prevalence ratios (PRs), risk ratios, and 95% confidence intervals (CIs) for the following sleep dimensions: short sleep duration (<7 hours), nonrestorative sleep (NRS, waking rested <4 days/week), and insomnia symptoms (difficulty falling/staying asleep). At baseline, participants reported: importance of faith, religion/spirituality as a source of strength/comfort ('very-to-somewhat' vs.
Neurol Ther
September 2025
Dayton Psychiatric Associations, Dayton, OH, USA.
Introduction: Tardive dyskinesia (TD), a persistent and often debilitating movement disorder, is associated with prolonged exposure to dopamine receptor-blocking agents. Individuals aged ≥ 60 years are at increased risk for TD and TD-related burden (e.g.
View Article and Find Full Text PDF